No Data
Viking Therapeutics Draws Neutral Rating at Goldman Sachs on Competitive Headwinds
The European Union's pharmaceutical industry warns that the U.S. tariffs could accelerate the relocation of the industry.
In a meeting held this Tuesday, European pharmaceutical companies warned Ursula von der Leyen, President of the European Commission, that the USA's proposed tariff policy may accelerate the trend of European pharmaceutical Industry migrating to the USA.
Trump Administration Reverses Biden's Plan For Medicare Coverage Of Obesity Drugs Like Ozempic And Zepbound
Eli Lilly Looks to End Selloff as Goldman Upgrades on Attractive Entry Point
Top Gap Ups and Downs on Monday: AZN, NVS, UL and More
Market Chatter: Novo Nordisk to Invest $1.09 Billion in Brazil Production Expansion